Akero Therapeutics Inc’s filing revealed that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.12 million on Apr 01 ’24. In the deal valued at $24.38 per share,5,000 shares were sold. As a result of this transaction, Young Jonathan now holds 263,306 shares worth roughly $6.11 million.
Then, Cheng Andrew sold 1,969 shares, generating $55,782 in total proceeds. Upon selling the shares at $28.33, the President and CEO now owns 589,447 shares.
Before that, White William Richard sold 724 shares. Akero Therapeutics Inc shares valued at $20,511 were divested by the Chief Financial Officer at a price of $28.33 per share. As a result of the transaction, White William Richard now holds 49,630 shares, worth roughly $1.15 million.
Cantor Fitzgerald initiated its Akero Therapeutics Inc [AKRO] rating to an Overweight in a research note published on September 19, 2023; the price target was $69. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Morgan Stanley also remained covering AKRO and has increased its forecast on January 27, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Evercore ISI revised its rating on September 14, 2022. It rated AKRO as “an Outperform” which previously was an “an In-line”.
Price Performance Review of AKRO
On Friday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock jump 1.09% to $23.22. Over the last five days, the stock has lost -8.08%. Akero Therapeutics Inc shares have fallen nearly -0.56% since the year began. Nevertheless, the stocks have fallen -38.54% over the past one year. While a 52-week high of $58.38 was reached on 03/04/24, a 52-week low of $11.25 was recorded on 02/06/24. SMA at 50 days reached $24.42, while 200 days put it at $30.71. A total of 0.53 million shares were traded, compared to the trading of 0.68 million shares in the previous session.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 22.32, which if violated will result in even more drops to 21.42. On the upside, there is a resistance level at 23.81. A further resistance level may holdings at 24.40. The Relative Strength Index (RSI) on the 14-day chart is 39.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.68%. Stochastics %K at 13.06% indicates the stock is a buying.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on Mar 15, 2024, growing by 0.58 million shares to a total of 9.47 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 8.89 million shares. There was a rise of 6.12%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 14.04% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.3.
